News about Drug Discovery & Development

Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201

Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety

Drug Discovery & Development | 26/03/2024 | By Manvi |  993

NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004

NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.

Drug Discovery & Development | 22/03/2024 | By Manvi |  442

Romaco Tecpharm Develops New ERS for Tablet Coaters

Romaco Tecpharm has announced the development of a new energy recovery system (ERS) for tablet coaters.

Drug Discovery & Development | 19/03/2024 | By Manvi |  242

New Marketing Code for Pharma Industry Issued by Indian Govt

The Department of Pharmaceuticals has issued a new code prohibiting pharma companies from offering gifts and travel facilities to healthcare professionals or their family members.

Drug Discovery & Development | 19/03/2024 | By Manvi |  766

Eureka Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS T-cell Therapy

This milestone represents one of the first engineered T-cell programs targeting solid tumors to reach Phase II.

Drug Discovery & Development | 18/03/2024 | By Manvi |  429

Biotheus Expanded Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates

Biotheus will grant Hansoh Pharma a license to use the proprietary anti-EGFR/cMet bispecific antibody PM1080/HS-20117 independently developed by Biotheus for the development of antibody-drug conjugates products (ADC Product).

Drug Discovery & Development | 16/03/2024 | By Manvi |  704

Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody

The companies have successfully completed the Good Manufacturing Practice (GMP) manufacturing of MOv18 IgE, Epsilogen’s leading IgE antibody drug candidate.

Drug Discovery & Development | 07/03/2024 | By Abha |  705

CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction

The company’s Clean Quick Viral DNA/RNA (CE-IVD) extracts viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples preserved in an inactivating viral transport medium.

Drug Discovery & Development | 06/03/2024 | By Manvi |  477

LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences

The platform debuts alongside Coherus' UDENYCA® on-body injector (OBI), a solution for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim utilized post-chemotherapy to mitigate infection risks.

Drug Discovery & Development | 29/02/2024 | By Manvi |  1480

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System

Accuray Incorporated announced that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company's Radixact® radiation therapy delivery system.

Drug Discovery & Development | 13/02/2024 | By Manvi |  259